Modulate Bio Inc.
PrivateLast Round
Seed Round
Apr 7, 2026
Total Funding Raised
$1.66M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Modulate Bio Inc. is a biotechnology company developing novel, differentiated GABAA positive allosteric modulators to treat neurological disorders including Essential Tremor, epilepsy, and anxiety.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Modulate Bio Inc. Comparables
Compare Modulate Bio Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gabather AB | 78% | |
| AgeneBio, Inc. | 77% | |
| AtaiBeckley Inc. | 76% |
Modulate Bio Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 7, 2026 | ||||
| Seed | Jun 12, 2025 | ||||
| Pre Seed | Oct 23, 2024 | ||||
| Grant | Jan 1, 2024 | ||||
| Accelerator | Dec 13, 2023 | ||||
Grant | Sep 26, 2022 |
Key People
Founding team and executive leadership
Modulate Bio Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bija Ventures | Seed Round, Seed |
| Harvard Innovation Labs | Grant |
| Pillar VC | Seed Round, Accelerator, Pre Seed, Seed |
| Blavatnik Fellowship in Life Science Entrepreneurship | Grant |
| Novaterra | Seed Round, Pre Seed, Seed |
| Nucleate | Accelerator |
| Phoenix Investment Club | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
$785K raised in Seed Round funding.
- Jan 21, 2026
Monthly visitors increased 856% MoM, from 131 to 1.3K.
Modulate Bio Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Modulate Bio Inc.'s valuation, stock price, and market status.
Is Modulate Bio Inc. a public or private company?
Modulate Bio Inc. is a private company.
What is the current stock price of Modulate Bio Inc.?
Modulate Bio Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Modulate Bio Inc. worth (valuation)?
Valuation information for Modulate Bio Inc. is not publicly available.
Can I buy Modulate Bio Inc. stock?
Modulate Bio Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Modulate Bio Inc.'s last funding round?
Modulate Bio Inc.'s most recent funding round was Seed Round on April 7, 2026.
Who are the main investors in Modulate Bio Inc.?
Key investors in Modulate Bio Inc. include Bija Ventures, Harvard Innovation Labs, Pillar VC, Blavatnik Fellowship in Life Science Entrepreneurship, Novaterra.
Will Modulate Bio Inc. IPO soon?
No public IPO plans have been announced for Modulate Bio Inc..
How can I track Modulate Bio Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Modulate Bio Inc.'s secondary market activity and sign up for updates.